This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Tosoh Corporation, Yokohama City University. Active years: 2023-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 922 
1 out of 57 
Years Active: 2023-2024
Title: Innovations in Cancer Detection by Shohei Myoba
Introduction
Shohei Myoba is a prominent inventor based in Ayase, Japan. He has made significant contributions to the field of cancer detection, holding 2 patents that focus on innovative methods and reagents for identifying various types of cancer.
Latest Patents
Myoba's latest patents include groundbreaking methods for detecting cancers and a detection reagent. The first patent provides a method for detecting cancer in a simple and highly accurate manner. This method involves measuring the levels of intact growth and differentiation factor (GDF15) propeptide and its fragments in a sample. It is designed to detect several types of cancer, including stomach, pancreatic, colorectal, lung, breast, and esophageal cancers. Additionally, it distinguishes between non-small cell lung cancer and small cell lung cancer. The reagent developed for this method includes an antibody that specifically recognizes GDF15 propeptide.
The second patent focuses on detecting castration-resistant prostate cancer (CRPC). This invention aims to provide a straightforward and accurate method for detecting CRPC by measuring the level of GDF15 propeptide in a sample. This novel detection marker helps identify the acquisition of castration resistance in prostate cancer patients during or after endocrine therapy. Similar to the first patent, the detection reagent for CRPC also includes an antibody that specifically recognizes GDF15 propeptide.
Career Highlights
Throughout his career, Myoba has worked with notable organizations, including Tosoh Corporation and Yokohama City University. His work has significantly impacted the field of cancer research and detection.
Collaborations
Myoba has collaborated with esteemed colleagues such as Norihisa Ohtake and Noriaki Arakawa. Their combined expertise has contributed to the advancement of cancer detection technologies.
Conclusion
Shohei Myoba's innovative work in cancer detection showcases his commitment to improving diagnostic methods. His patents reflect a significant advancement in the fight against cancer, providing new tools for early detection and treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile